Skip to content
PICO Portalanswers from OpenAlex

Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis

PaperCitations, authors & open-access status

Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis is a paper indexed in PICO Portal from OpenAlex.

How many citations does Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis have?

PICO Portalcitation count

Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis has 58 citations in the OpenAlex counts PICO Portal stores.

When was Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis published?

PICO Portalyear

Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis has 2013 year in the PICO Portal index.

What is the open-access status of Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis?

PICO Portaloa status

Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis has closed oa status in the PICO Portal index.

What is the DOI of Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis?

PICO Portaldoi

The DOI for Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis is on the source record.

What is the PMID of Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis?

PICO Portalpmid

The PMID for Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis is on the source record.

What is the OpenAlex record for Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis?

PICO Portalopenalex

The OpenAlex for Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental Atherosclerosis is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial